Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06719518 · ClinicalTrials.gov registry record

Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device

A clinical trial of Blood Pressure, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06719518 is a study of Blood Pressure that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06719518, a study of Blood Pressure, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range.

Conditions Studied

Interventions

  • DEVICE ViTrack device

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-12-17
Est. Completion 2026-07-31

What the Registry Record Tells You About NCT06719518

The ClinicalTrials.gov registry entry for NCT06719518 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which ViTrack device is the first listed.

NCT06719518 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06719518 about?

NCT06719518 is a clinical study titled "Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device". The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range.

What is the current status of trial NCT06719518?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-12-17. Estimated completion is 2026-07-31.

What conditions does trial NCT06719518 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06719518?

The interventions under investigation include: ViTrack device (DEVICE).

Who is sponsoring clinical trial NCT06719518?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06719518 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.